PLN 8.05
(0.25%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 37.49 Million PLN | -10.51% |
2022 | 41.89 Million PLN | -14.8% |
2021 | 49.17 Million PLN | 135.08% |
2020 | 20.91 Million PLN | 79.06% |
2019 | 11.68 Million PLN | 54.72% |
2018 | 7.55 Million PLN | 54.02% |
2017 | 4.9 Million PLN | 236.62% |
2016 | 1.45 Million PLN | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 35.75 Million PLN | -1.39% |
2024 Q1 | 36.25 Million PLN | -3.29% |
2023 Q3 | 39.66 Million PLN | -1.79% |
2023 Q4 | 37.49 Million PLN | -5.47% |
2023 FY | 37.49 Million PLN | -10.51% |
2023 Q1 | 40.54 Million PLN | -3.23% |
2023 Q2 | 40.38 Million PLN | -0.39% |
2022 Q3 | 43.1 Million PLN | -0.94% |
2022 Q2 | 43.51 Million PLN | -2.77% |
2022 Q4 | 41.89 Million PLN | -2.81% |
2022 Q1 | 44.76 Million PLN | -8.98% |
2022 FY | 41.89 Million PLN | -14.8% |
2021 FY | 49.17 Million PLN | 135.08% |
2021 Q3 | 44.4 Million PLN | 87.53% |
2021 Q4 | 49.17 Million PLN | 10.76% |
2021 Q1 | 21.01 Million PLN | 0.44% |
2021 Q2 | 23.67 Million PLN | 12.68% |
2020 Q4 | 20.91 Million PLN | 113.67% |
2020 FY | 20.91 Million PLN | 79.06% |
2020 Q3 | 9.79 Million PLN | -7.92% |
2020 Q2 | 10.63 Million PLN | 7.03% |
2020 Q1 | 9.93 Million PLN | -14.97% |
2019 Q3 | 11.85 Million PLN | 113.61% |
2019 Q2 | 5.55 Million PLN | 13.36% |
2019 Q1 | 4.89 Million PLN | -35.16% |
2019 FY | 11.68 Million PLN | 54.72% |
2019 Q4 | 11.68 Million PLN | -1.47% |
2018 Q1 | - PLN | -100.0% |
2018 Q2 | 5.34 Million PLN | 0.0% |
2018 Q3 | 7.73 Million PLN | 44.7% |
2018 FY | 7.55 Million PLN | 54.02% |
2018 Q4 | 7.55 Million PLN | -2.38% |
2017 FY | 4.9 Million PLN | 236.62% |
2017 Q4 | 4.9 Million PLN | 0.0% |
2016 FY | 1.45 Million PLN | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Adiuvo Investments S.A. | 2.2 Million PLN | -1599.592% |
Genomtec S.A. | 16.04 Million PLN | -133.63% |
Medicalgorithmics S.A. | 121.63 Million PLN | 69.175% |
Synektik Spólka Akcyjna | 297.32 Million PLN | 87.39% |